Amgen to terminate participation in co-development and commercialization of brodalumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. BIRK

Go back to Amgen to terminate participation in co-development and commercialization of brodalumab
Amgen Inc (NASDAQ: AMGN) Delayed: 417.84 +1.66 (0.40%)
Previous Close $416.18    52 Week High $176.85 
Open $419.92    52 Week Low $133.64 
Day High $420.26    P/E 62.93 
Day Low $415.78    EPS $6.64 
Volume 2,777,894       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,598,058       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 19.07 -0.22 (1.14%)
Previous Close $19.29    52 Week High $18.64 
Open $19.16    52 Week Low $12.59 
Day High $19.19    P/E N/A 
Day Low $19.07    EPS $0.00 
Volume 13,377